Thiazolidinediones for type 2 diabetes - No evidence exists that pioglitazone induces hepatic cytochrome P450 isoform CYP3A4

被引：8

作者：

Glazer, NB ^{[1
]}

Cheatham, WW ^{[1
]}

机构：

[1] Takeda Pharmaceut Amer, Lincolnshire, IL 60069 USA

来源：

关键词：

D O I：

10.1136/bmj.322.7280.235

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：235 / 236

页数：4

共 5 条

[1] THE INCREASE IN URINARY-EXCRETION OF 6-BETA-HYDROXYCORTISOL AS A MARKER OF HUMAN HEPATIC CYTOCHROME-P450IIIA INDUCTION
GED, C
ROUILLON, JM
PICHARD, L
COMBALBERT, J
BRESSOT, N
BORIES, P
MICHEL, H
BEAUNE, P
MAUREL, P
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (04) : 373 - 387
[2] Ishii T, 2000, DIABETES, V49, pA112
[3] Thiazolidinediones for type 2 diabetes - New agents reduce insulin resistance but need long term clinical trials
Krentz, AJ
Bailey, CJ
Melander, A
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7256): : 252 - 253
[4] *SMITHKL BEECH, 2000, AVANDIA PRESCR INF
[5] *TAK PHARM AM, 1999, ACTOS PRESCR INF